CClinicalTrials.gg
RecruitingNCT06574113Updated Aug 28, 2024

Validation of Cuffless Blood Pressure Measurements Using the Perin Health Patch

An observational study in Blood Pressure, sponsored by Perin Health Devices. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-28.

Sponsored by Perin Health Devices · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
85
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to validate a proprietary cuffless blood pressure algorithm using measurements from a multi-modal chest-worn medical device, the Perin Health Patch (PHP).

Read the detailed description

The study will compare the performance of the PHP to an ambulatory blood pressure cuff across 85 subjects for a 10-minute monitoring period, followed by an optional cold pressor test and an additional 10-minute monitoring period. The study aims to confirm that the calibrated measurement from the wearable device meets AAMI performance standards.

02

Conditions studied

  • Blood Pressure

Keywords

  • Cuffless blood pressure
  • Wearable device
03

In context

Lead sponsor

Perin Health Devices is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of male and female adult participants aged 18 years or older who are willing and able to provide informed consent and comply with the study procedures. Participants may be healthy or have comorbidities, so long as participants are members of any 'Special Population' as defined by the AAMI standards, including but not limited to pregnant individuals, children, and those with an arm circumference greater than 42 cm. Due to the nature of the investigational device, individuals with pacemakers or a history of reactions to medical adhesives may not participate.

Inclusion criteria

  • Adults aged 18 years or older,
  • Willing and able to provide informed consent,
  • Able to comply with study procedure.

Exclusion criteria

Exclusion Criteria:

  • Any member defined under 'Special Population' in the AAMI standards (Pregnant, children, arm circumference > 42 cm),
  • Patient with a pacemaker,
  • History of reactions to medical adhesives,
  • Inability to comply with the study procedure,
  • Non-English Speaker.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
85 participants (estimated)
Patient registry
No

Interventions

  • DevicePerin Health Patch

    The Perin Health Patch (PHP)is a multimodal wearable health patch, which combines auscultation, electrocardiography (ECG), pulse oximetry via photoplethysmography (PPG), bioimpedance (BioZ), skin temperature, and motion and tilt sensors. The PHP integrates multiwavelength PPG (MWPPG) with blue, green, red, and IR LEDs, allowing for precise calculation of PTT, PWV, and related unique parameters, that are used for the calculation of cuffless blood pressure.

06

What researchers measure

Primary outcomes

  1. Cuffless blood pressure measurement performance

    Calculate the mean error and standard deviation of blood pressure (BP) measurements from the PHP relative to the ambulatory blood pressure cuff and determine compliance of the PHP's performance with AAMI standards and ISO 81060-2.

    Time frame: 3 months

Secondary outcomes

  1. Demographic performance variance

    Determine any variations in performance on certain demographic groups, including subjects who are overweight, subjects with dark skin pigmentation, or subjects with comorbidities.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Perin Health Devices
    Woodland Hills, California 91364, United States
    Recruiting
08

References and documents

Study documents

  • Protocol, analysis plan and consent form · Jun 3, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — Access to the data will be restricted to the study team. If any future or secondary analysis is conducted by other investigators, a formal approval process will be undertaken, including the validation of proper training certificates and data use plans. Training, requests, and approvals will be maintained in Perin Health Devices' electronic quality management system (eQMS). PI McLane will be responsible for the oversight of the electronic and physical data.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06574113
Lead sponsor
Perin Health Devices
Responsible party
Sponsor
First posted
Aug 27, 2024
Start date
Aug 15, 2024
Primary completion
Oct 15, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Aug 28, 2024

Study contacts

Ian M McLane, Ph.D.
Contact
imclane@phasemargin.com
8186069389
Valerie Rennoll, Ph.D.
Contact
vrennoll@phasemargin.com
Ian M McLane, Ph.D.
principal investigator · Perin Health Devices

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion